No profile data available.
AngioDynamics, Inc. (ANGO) is a healthcare company in the various healthcare equipment manufacturing industry, based in Latham, United States, with about 632 full-time employees.
It reported revenue of $320.17 million for fiscal year 2026, up 9.5% from fiscal year 2025, and net income of -$36.74 million. In Q1 2027 (the quarter ended August 31, 2026) revenue was $80.92 million, up 6.9% from a year before. Its largest business segment, Med Device, brought in 53% of segment revenue in fiscal year 2026; United States was the largest region with 86%. Its market capitalization was $484.47 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended May 31, 2026; market data as of October 9, 2026.
, a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
AngioDynamics reported $320.17 million in revenue for fiscal year 2026, up 9.5% from $292.50 million in fiscal year 2025. In Q1 2027 revenue was $80.92 million.
Med Device, with $170.22 million or 53% of segment revenue in fiscal year 2026. Next: Med Tech (47%).
United States: 86% of revenue by region in fiscal year 2026, followed by International (14%).
$484.47 million as of October 9, 2026.
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Butterfly Network, Inc. (BFLY), Artivion, Inc. (AORT), MiMedx Group, Inc. (MDXG), Profound Medical Corp. (PROF).